Dynamik der portalen Hypertension und Anwendbarkeit nicht-invasiver Tests nach Rekompensation bei alkoholbedingter Leberzirrhose
Benedikt Hofer(Austrian Academy of Sciences), Thomas Reiberger(ERN GUARD-Heart), Benedikt Simbrunner(Medical University of Vienna), Natalia Dominik(National Hospital for Neurology and Neurosurgery), M Trauner(Medical University of Vienna), Gero Kramer(Memorial Sloan Kettering Cancer Center), M Hintersteininger(Medical University of Vienna), Albert Friedrich Stättermayer(Medical University of Vienna), Christian Sebesta(Donauspital), Lorenz Balcar(Medical University of Vienna), M Mandorfer(Medical University of Vienna), G Semmler(Medical University of Vienna), Paul Thöne(Medical University of Vienna)
Cited by 0
Related Papers
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation
|Journal of Hepatology|2024|239
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
|Journal of Hepatology|2020|202
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis
|Clinical Gastroenterology and Hepatology|2022|130